Can exercise, diet, and counseling beat fatigue in PBC?
NCT ID NCT07161245
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a program combining exercise, nutritional advice, and psychological support can reduce fatigue in people with primary biliary cholangitis (PBC). 64 participants with moderate to severe fatigue will be randomly assigned to either the rehab program or standard care. The goal is to see if this non-drug approach improves fatigue, quality of life, and cognitive symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- multimodal rehabilitation program (exercise, nutritional counseling, psychological support)
- What this could lead to
- If it works, this could offer a non-drug way to reduce fatigue and improve quality of life for people with primary biliary cholangitis.
- What could go wrong
- This is a small, early-phase trial with only 64 participants. The program requires significant commitment, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 64 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥18 years * PBC diagnosis according to EASL guidelines * Moderate - severe fatigue defined by ≥ 29 points in PBC-40 questionnaire Exclusion Criteria: * Age \> 80 years * Severe pruritus * Decompensated cirrhosis * Other causes of liver disease than PBC * Liver transplant (LT) o placement on a waiting-list for LT * Uncontrolled thyroid disesase * Anemia with haemoglobin \<11g/dl * Uncontrolled cardiovascular risk factors * BMI \> 35, * Acute myocardial infarct or unstable angina the past 6 months * Muscle disease or systemic disease with potential muscle involvement * Dysautonomy * Untreated osteoporosis * Untreated celiac disease * Alcohol consumption \> 14 standard drinks (SD) in women and \>21 (SD) in men per week * Chronic kidney disease ≥ 4 KDIGO stage * Malignancy in the past two years (except for non melanoma skin cancer and in situ cervical carcinoma) * Not capable of performing or following the prehabilitation program * Involvement in a clinical trial the previous 2 months * Refusal of informed consent For the study of the pathophysiology of fatigue, additional exclusion criteria will be established: Severe depression or neuropsychiatric disease, 2) Treatment with centrally acting drugs, 3) Muscular or systemic disease with potential muscle involvement, 4) Immunosuppressive treatment, 5) Sleep disorder, 6) Obesity (BMI \>30).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Primary biliary cholangitis (PBC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hospital Clinic de Barcelona
RECRUITINGBarcelona, Barcelona, 08036, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spanish databases used to map a rare liver disease
- Can a T-Cell signature unlock the secrets of autoimmune liver disease?
- Can a common cholesterol drug help manage a rare liver disease?
- One pill may tame both itchy skin and stubborn liver disease
- Can a smartwatch help manage a rare liver disease? stanford study investigates
- Can breathing and meditation ease PBC symptoms? new study says maybe.